GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In VivoWALLIN, Jeffrey J; GUAN, Jane; PRIOR, Wei Wei et al.Clinical cancer research (Print). 2012, Vol 18, Num 14, pp 3901-3911, issn 1078-0432, 11 p.Article

Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth InhibitionHOEFLICH, Klaus P; MERCHANT, Mark; ENGST, Stefan et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 1, pp 210-219, issn 0008-5472, 10 p.Article

Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF^V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway SuppressionHOEFLICH, Klaus P; HERTER, Sylvia; STERN, Howard et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 3042-3051, issn 0008-5472, 10 p.Article

Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3' Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical ModelsO'BRIEN, Carol; WALLIN, Jeffrey J; BEIVIN, Marcia et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3670-3683, issn 1078-0432, 14 p.Article

In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer ModelsHOEFLICH, Klaus P; O'BRIEN, Carol; WEI ZHOU et al.Clinical cancer research (Print). 2009, Vol 15, Num 14, pp 4649-4664, issn 1078-0432, 16 p.Article

PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenograftsCHOO, Edna F; NG, Chee M; BERRY, Leanne et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 133-143, issn 0344-5704, 11 p.Article

Navitoclax Enhances the Efficacy of Taxanes in Non―Small Cell Lung Cancer ModelsTAN, Nguyen; MALEK, Mehnaz; JIPING ZHA et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1394-1404, issn 1078-0432, 11 p.Article

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment EfficacyBAGRI, Anil; BERRY, Leanne; ROSEN, Oliver et al.Clinical cancer research (Print). 2010, Vol 16, Num 15, pp 3887-3900, issn 1078-0432, 14 p.Article